Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halobetasol Lotion in Adolescents with Plaque Psoriasis
NCT03212963Phase 4Terminated
- Sponsor
- Sun Pharma
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Halobetasol propionate 0.05% lotion in plaque psoriasis, sponsored by Sun Pharma. Primary endpoints: Investigator's Global Assessment at Day 15, Percent BSA Affected With Disease at Day 15 and 2 more. Started Mar 2017; status: terminated.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03212963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212963.